Novartis | NOVN - PE Price to Earnings

Stock Price
128.10
Daily Change
-1.70 -1.31%
Monthly
9.94%
Yearly
31.24%
Q1 Forecast
123.39

Novartis reported $15.74 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Alcon AG USD 34.4 4.64 Sep/2025
Almirall EUR 79.43 0.3 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Bayer EUR 5.93 0.68 Sep/2025
Biogen USD 14.02 4.63 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Fresenius EUR 15.18 0.63 Dec/2025
Fresenius Medical Care EUR 8.71 1.86 Dec/2025
Galapagos EUR 53.92 0 Mar/2025
Genmab DKK 12.75 0.62 Sep/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
GRIFOLS EUR 16.81 28.19 Sep/2025
Hikma Pharmaceutical USD 14.14 5.42 Jun/2025
J&J USD 23.62 0.86 Dec/2025
Lonza CHF 67.52 12.2 Jun/2024
Merck EUR 13.37 0.13 Sep/2025
Merck USD 13.92 5.08 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Novo Nordisk DKK 12.78 0.01 Dec/2025
Orion EUR 28.54 2.43 Dec/2025
Pfizer USD 14.48 5.18 Dec/2025
Philips EUR 15.65 4.36 Dec/2025
Recordati EUR 25.3 1.41 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
UCB EUR 35.22 3.9 Jun/2025